Nucana Stock Soars 10.53% on Bullish Analyst Ratings

On July 1, 2025, Nucana's stock surged by 10.53% in pre-market trading, marking a significant uptick in investor interest and confidence in the company's prospects.

Analysts have recently rated Nucana (NCNA) stock as a Buy, with a price target of $150.00. This positive outlook is likely contributing to the recent surge in stock price, as investors respond to the bullish sentiment from market experts.

Additionally, the short interest ratio for Nucana has seen a notable increase of 66.43% from the previous month. This rise in short interest suggests that there is a growing number of investors betting against the stock, which could indicate potential volatility in the near future.